title: Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
abstract: Fibroblast activation protein (FAP), a membrane prolyl-specific proteinase with both dipeptidase and endopeptidase activities, is overexpressed by reactive stromal fibroblasts during epithelial-derived cancer growth. FAP digests extracellular matrix as tissue is remodeled during cancer expansion and may also promote an immunotolerant tumor microenvironment. Recent studies suggest that nonspecific FAP inhibitors suppress human cancer xenografts in mouse models. Prolyl oligopeptidase (POP), another prolyl-specific serine proteinase, is also elevated in many cancers and may have a regulatory role in angiogenesis promotion. FAP and POP cell-associated activities may be targets for diagnosis and treatment of various cancers, but their accessibilities to highly effective specific inhibitors have not been shown for cells important to cancer growth. Despite their frequent simultaneous expression in many cancers and their overlapping activities toward commonly used substrates, precise, separate measurement of FAP or POP activity has largely been ignored. To distinguish each of the two activities, we synthesized highly specific substrates and inhibitors for FAP or POP based on amino acid sequences surrounding the scissile bonds of their respective putative substrates. We found varying amounts of FAP and POP protein and activities on activated fibroblasts, mesenchymal cells, normal breast cells, and one breast cancer cell line, with some cells exhibiting more POP than FAP activity. Replicating endothelial cells (ECs) expressed POP but not FAP until tubulogenesis began. Targeting FAP-positive cells, especially mesenchymal stem cells and cancer-associated fibroblasts for inactivation or destruction, and inhibiting POP-producing EC may abrogate stromal invasion and angiogenesis simultaneously and thereby diminish cancer growth.
authors.affiliation: William K Warren Medical Research Center and Department of Medicine, University of Oklahoma College of Medicine, Oklahoma City, OK 73126, USA.
authors.forename: Victoria J
authors.initials: VJ
authors.lastname: Christiansen
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Jackson
authors.forename: Kyung N
authors.initials: KN
authors.lastname: Lee
authors.forename: Tamyra D
authors.initials: TD
authors.lastname: Downs
authors.forename: Patrick A
authors.initials: PA
authors.lastname: McKee
mesh_terms: D000595:Amino Acid Sequence; D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D010450:Endopeptidases; D042783:Endothelial Cells / Q000201:enzymology; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology; D018093:Gelatinases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D059630:Mesenchymal Stem Cells / Q000201:enzymology; D055806:Microvessels / Q000473:pathology; D008969:Molecular Sequence Data; D009362:Neoplasm Metastasis; D009842:Oligopeptides / Q000494:pharmacology*; D000085822:Prolyl Oligopeptidases; D012697:Serine Endopeptidases / Q000737:chemistry / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D059016:Tumor Microenvironment; D000099167:Fibroblast Activation Protein Alpha
chemical_list: D000970:Antineoplastic Agents; D010450:Endopeptidases; D018093:Gelatinases; D008565:Membrane Proteins; D009842:Oligopeptides; D000085822:Prolyl Oligopeptidases; D012697:Serine Endopeptidases; D015842:Serine Proteinase Inhibitors; D000099167:Fibroblast Activation Protein Alpha; C583461:acetyl-Arg-AEEA-(d)Ala-(l)boroPro; C583460:acetyl-Lys-Leu-Arg-(l)boroPro; C000705287:PREPL protein, human
references.citation: Cancer Biol Ther. 2007 Nov;6(11):1691-9
references.pmid: 18032930
references.citation: Cancer Biol Ther. 2012 Feb 1;13(3):123-9
references.pmid: 22236832
references.citation: Biol Chem. 2001 Nov;382(11):1563-73
references.pmid: 11767946
references.citation: Clin Cancer Res. 2003 May;9(5):1590-5
references.pmid: 12738710
references.citation: Front Biosci. 2008 Jan 01;13:3168-80
references.pmid: 17981786
references.citation: Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4
references.pmid: 2896356
references.citation: Ann N Y Acad Sci. 2010 Apr;1194:53-9
references.pmid: 20536450
references.citation: Anticancer Res. 2008 Sep-Oct;28(5A):2813-7
references.pmid: 19035315
references.citation: Curr Eye Res. 2009 Feb;34(2):112-7
references.pmid: 19219682
references.citation: In Vitro Cell Dev Biol Anim. 2000 Feb;36(2):77-80
references.pmid: 10718362
references.citation: Biochemistry. 2008 Jan 22;47(3):1076-86
references.pmid: 18095711
references.citation: Histopathology. 2009 Oct;55(4):432-40
references.pmid: 19817894
references.citation: Br J Haematol. 2008 Sep;142(5):827-30
references.pmid: 18510677
references.citation: Int Rev Cell Mol Biol. 2012;297:83-116
references.pmid: 22608558
references.citation: Eur J Clin Chem Clin Biochem. 1996 Jan;34(1):17-22
references.pmid: 8704029
references.citation: Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):121-7
references.pmid: 18221031
references.citation: Blood. 2007 Jun 15;109(12):5286-92
references.pmid: 17317851
references.citation: Thromb Haemost. 2003 Mar;89(3):561-72
references.pmid: 12624642
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
references.pmid: 2402505
references.citation: Curr Opin Chem Biol. 2003 Aug;7(4):496-504
references.pmid: 12941425
references.citation: Curr Protein Pept Sci. 2008 Feb;9(1):96-107
references.pmid: 18336325
references.citation: Arch Biochem Biophys. 2007 Jan 15;457(2):177-86
references.pmid: 17174263
references.citation: Br J Pharmacol. 2011 Aug;163(8):1666-78
references.pmid: 21133893
references.citation: Cancer Res. 1993 Jul 15;53(14):3327-35
references.pmid: 8391923
references.citation: Exp Cell Res. 2009 Apr 15;315(7):1234-46
references.pmid: 19331819
references.citation: Arthritis Res Ther. 2006;8(6):R171
references.pmid: 17105646
references.citation: Future Oncol. 2010 Mar;6(3):347-9
references.pmid: 20222791
references.citation: Cancer Res. 2008 Jun 1;68(11):4331-9
references.pmid: 18519693
references.citation: Expert Opin Ther Targets. 2009 Aug;13(8):967-73
references.pmid: 19606930
references.citation: J Natl Cancer Inst. 2012 Sep 5;104(17):1320-34
references.pmid: 22911669
references.citation: J Biol Chem. 1995 Jun 9;270(23):14107-14
references.pmid: 7539799
references.citation: J Pathol. 2010 Sep;222(1):1-15
references.pmid: 20681009
references.citation: Nature. 2007 Oct 4;449(7162):557-63
references.pmid: 17914389
references.citation: J Thromb Haemost. 2011 May;9(5):987-96
references.pmid: 21251197
references.citation: Oncology. 2003;65(4):363-70
references.pmid: 14707457
references.citation: Front Biosci. 2008 Jan 01;13:2319-26
references.pmid: 17981714
references.citation: Biochemistry. 2009 Jun 16;48(23):5149-58
references.pmid: 19402713
references.citation: Blood. 2006 Feb 15;107(4):1397-404
references.pmid: 16223769
references.citation: Regul Pept. 2010 Aug 9;163(1-3):102-6
references.pmid: 20362629
references.citation: Int J Dev Biol. 2001 Apr;45(2):445-7
references.pmid: 11330865
references.citation: Clin Exp Metastasis. 2011 Aug;28(6):567-79
references.pmid: 21604185
references.citation: J Biol Chem. 1999 Dec 17;274(51):36505-12
references.pmid: 10593948
references.citation: J Clin Invest. 2009 Dec;119(12):3613-25
references.pmid: 19920354
references.citation: Science. 2010 Nov 5;330(6005):827-30
references.pmid: 21051638
references.citation: Blood. 2004 May 15;103(10):3783-8
references.pmid: 14751930
references.citation: Cell. 2009 Nov 25;139(5):871-90
references.pmid: 19945376
references.citation: Cancer Res. 2004 Apr 15;64(8):2712-6
references.pmid: 15087384
references.citation: Hum Pathol. 2006 Mar;37(3):352-60
references.pmid: 16613331
references.citation: Int J Cancer. 1997 May 2;71(3):383-9
references.pmid: 9139873
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61
references.pmid: 7911242
references.citation: Peptides. 2007 Nov;28(11):2146-54
references.pmid: 17904692
references.citation: Am J Pathol. 2008 May;172(5):1381-90
references.pmid: 18403594
references.citation: Neuropeptides. 2007 Feb;41(1):1-24
references.pmid: 17196652
references.citation: Br J Haematol. 2006 Apr;133(1):83-92
references.pmid: 16512833